Standard Treatment Recommendations for Advanced Gastroenteropancreatic Neuroendocrine Carcinomas (GEP-NECs)

被引：0

作者：

Smith, Abraham T. ^{[1
]}

机构：

[1] Univ Penn, Perelman Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA

来源：

JOURNAL OF THE PANCREAS | 2022年 / 23卷 / 07期

关键词：

Pancreas; Pancreatitis; Pancreatic cell electrical activity; Insulin secretion;

D O I：

10.35841/1590-8577-23.7.757

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Gastroenteropancreatic Neuroendocrine Carcinomas (GEP-NETs), also known as carcinoids and islet cell tumours, are tumours produced from neuroendocrine cells that can arise anywhere along the gastrointestinal system. They are a diverse family of neoplasms with a broad and complex clinical range. Neuroendocrine tumours are tumours that arise in neuroendocrine cells, which are specialized cells. Neuroendocrine cells share characteristics with nerve cells and hormone-producing cells. Neuroendocrine tumours are uncommon and can develop anywhere in the body. Endocrinol cells found in the gastroenteric mucosa as well as those found in the pancreas, mostly comprising islets of Langerhans, are referred to as Gastroenteropancreatic (GEP) endocrine cells.

引用

页码：68 / 69

页数：2

共 50 条

[21] Early Evaluation of Sunitinib in Treatment of Advanced Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs) by CT Imaging: RECIST or Choi Criteria?
Luo, Y.
Chen, J.
Li, Z. P.
Feng, S. T.
NEUROENDOCRINOLOGY, 2016, 103 : 82 - 82
[22] Clinical Characteristics and Treatment Outcome of Advanced G3 Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)- A Retrospective Analysis
Grigorescu, R. R.
Stanel, I
Gramaticu, I
Dinu, I
Buica, F.
Luca, I
Dima, S.
Dumitrascu, T.
Petcu, C.
Miron, M.
Gheorghe, C.
Croitoru, A.
NEUROENDOCRINOLOGY, 2017, 105 : 77 - 77
[23] Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors
Allaw, Mohammed B.
Switchenko, Jeffrey M.
Khalil, Lana
Wu, Christina
Alese, Olatunji B.
Akce, Mehmet
Draper, Amber
Jones, Aaron T.
El-Rayes, Bassel
Shaib, Walid
ONCOLOGY, 2022, : 131 - 139
[24] SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) 2014
Garcia-Carbonero, R.
JImenez-Fonseca, P.
Teule, A.
Barriuso, J.
Sevilla, I.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (12): : 1025 - 1034
[25] SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) 2014
R. Garcia-Carbonero
P. JImenez-Fonseca
A. Teulé
J. Barriuso
I. Sevilla
Clinical and Translational Oncology, 2014, 16 : 1025 - 1034
[26] SYSTEMIC TREATMENT OF GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS (GEP-NETS): CURRENT APPROACHES AND FUTURE OPTIONS
Strosberg, Jonathan R.
ENDOCRINE PRACTICE, 2014, 20 (02) : 167 - 175
[27] Expression of Somatostatin Receptors in Gastroenteropancreatic Neuroendocrine Neoplasm and Multicenter Retrospective Clinical Study of Octreotide LAR in the Treatment of Advanced GEP-NET
Yuhong, W.
Wei, W.
Kaizhou, J.
Cheng, F.
Zhiwei, Z.
Chenghao, S.
Minhu, C.
Xianjun, Y.
Jie, C.
NEUROENDOCRINOLOGY, 2016, 103 : 76 - 76
[28] Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications
Fazio, Nicola
Milione, Massimo
CANCER TREATMENT REVIEWS, 2016, 50 : 61 - 67
[29] Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study
Cwikla, J. B.
Sankowski, A.
Seklecka, N.
Buscombe, J. R.
Nasierowska-Guttmejer, A.
Jeziorski, K. G.
Mikolajczak, R.
Pawlak, D.
Stepien, K.
Walecki, J.
ANNALS OF ONCOLOGY, 2010, 21 (04) : 787 - 794
[30] Targeted Therapies (TT) (Sunitinib and Everolimus) for Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET). A Case Series
Perez de la Puente, C.
Mando, P.
Rizzo, M.
Rivero, S.
Pesce, V
Roca, E.
Chacon, M.
Chacon, R.
O'Connor, J. M.
NEUROENDOCRINOLOGY, 2017, 105 : 223 - 223

← 1 2 3 4 5 →